B2M and Miyoshi myopathy: An especially interesting case among our MM patients treated with THAL was the patient with an extremly long-term response to THAL therapy, achieved despite unfavourable prognostic factors at presentation, such as high serum β2M level, -13q deletion and MDR-1 gene expression.